Mydecine Innovations Group Inc. (MYCOF)
OTCMKTS · Delayed Price · Currency is USD
0.0027
-0.0038 (-58.33%)
At close: Aug 22, 2025
MYCOF Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
166.74K USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 7.49K | 4.88K | 186.32% |
| Dec 31, 2020 | 2.62K | -122.96K | -97.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Glass House Brands | 221.55M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 105.45M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.09M |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |
Mydecine Innovations Group News
- 2 months ago - Mydecine Innovations Group Provides Update On Annual Financial Statements - TheNewswire
- 2 months ago - Mydecine Innovations Group Provides Update on Annual Financial Statements - TheNewswire
- 3 months ago - Mydecine Innovations Group Provides Update on Annual Financial Statements - TheNewswire
- 3 months ago - Mydecine Innovations Group Provides Update on Annual Financial Statements - TheNewswire
- 4 months ago - Mydecine Innovations Group Announces Late Filing Of Annual Financial Statements And Management Cease Trade Order - TheNewswire
- 5 months ago - Mydecine Innovations Group Announces Changes To Board And Management - TheNewswire
- 1 year ago - Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds - GlobeNewsWire
- 1 year ago - Mydecine Innovations Group Announces Director Resignation - GlobeNewsWire